These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36401646)

  • 21. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
    Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
    JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketamine effects on default mode network activity and vigilance: A randomized, placebo-controlled crossover simultaneous fMRI/EEG study.
    Zacharias N; Musso F; Müller F; Lammers F; Saleh A; London M; de Boer P; Winterer G
    Hum Brain Mapp; 2020 Jan; 41(1):107-119. PubMed ID: 31532029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of D-cycloserine on negative symptoms in schizophrenia.
    Duncan EJ; Szilagyi S; Schwartz MP; Bugarski-Kirola D; Kunzova A; Negi S; Stephanides M; Efferen TR; Angrist B; Peselow E; Corwin J; Gonzenbach S; Rotrosen JP
    Schizophr Res; 2004 Dec; 71(2-3):239-48. PubMed ID: 15474895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans.
    Muthukumaraswamy SD; Shaw AD; Jackson LE; Hall J; Moran R; Saxena N
    J Neurosci; 2015 Aug; 35(33):11694-706. PubMed ID: 26290246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in interhemispheric gamma-band connectivity are related to the emergence of auditory verbal hallucinations in healthy subjects during NMDA-receptor blockade.
    Thiebes S; Steinmann S; Curic S; Polomac N; Andreou C; Eichler IC; Eichler L; Zöllner C; Gallinat J; Leicht G; Mulert C
    Neuropsychopharmacology; 2018 Jun; 43(7):1608-1615. PubMed ID: 29453445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity.
    Goff DC
    Curr Neuropharmacol; 2017; 15(1):21-34. PubMed ID: 26915421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans.
    D'Souza DC; Gil R; Cassello K; Morrissey K; Abi-Saab D; White J; Sturwold R; Bennett A; Karper LP; Zuzarte E; Charney DS; Krystal JH
    Biol Psychiatry; 2000 Mar; 47(5):450-62. PubMed ID: 10704956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study.
    Arendt-Nielsen L; Petersen-Felix S; Fischer M; Bak P; Bjerring P; Zbinden AM
    Anesth Analg; 1995 Jul; 81(1):63-8. PubMed ID: 7598284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI.
    Northoff G; Richter A; Bermpohl F; Grimm S; Martin E; Marcar VL; Wahl C; Hell D; Boeker H
    Schizophr Res; 2005 Jan; 72(2-3):235-48. PubMed ID: 15560968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled experimental study of hydrocortisone and D-cycloserine effects on fear extinction in PTSD.
    Inslicht SS; Niles AN; Metzler TJ; Lipshitz SL; Otte C; Milad MR; Orr SP; Marmar CR; Neylan TC
    Neuropsychopharmacology; 2022 Oct; 47(11):1945-1952. PubMed ID: 34799682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes.
    Watson GB; Bolanowski MA; Baganoff MP; Deppeler CL; Lanthorn TH
    Brain Res; 1990 Feb; 510(1):158-60. PubMed ID: 2157524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
    Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
    Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
    Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D
    Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.
    Krystal JH; Abi-Saab W; Perry E; D'Souza DC; Liu N; Gueorguieva R; McDougall L; Hunsberger T; Belger A; Levine L; Breier A
    Psychopharmacology (Berl); 2005 Apr; 179(1):303-9. PubMed ID: 15309376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of D-cycloserine on extinction of mesolimbic cue reactivity in alcoholism: a randomized placebo-controlled trial.
    Kiefer F; Kirsch M; Bach P; Hoffmann S; Reinhard I; Jorde A; von der Goltz C; Spanagel R; Mann K; Loeber S; Vollstädt-Klein S
    Psychopharmacology (Berl); 2015 Jul; 232(13):2353-62. PubMed ID: 25697860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
    Anand A; Charney DS; Oren DA; Berman RM; Hu XS; Cappiello A; Krystal JH
    Arch Gen Psychiatry; 2000 Mar; 57(3):270-6. PubMed ID: 10711913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine.
    Hong LE; Summerfelt A; Buchanan RW; O'Donnell P; Thaker GK; Weiler MA; Lahti AC
    Neuropsychopharmacology; 2010 Feb; 35(3):632-40. PubMed ID: 19890262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ketamine and N-methyl-D-aspartate on fluoxetine-induced antidepressant-related behavior using the forced swimming test.
    Owolabi RA; Akanmu MA; Adeyemi OI
    Neurosci Lett; 2014 Apr; 566():172-6. PubMed ID: 24530380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress.
    Scheeringa MS; Weems CF
    J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):69-77. PubMed ID: 24506079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cue exposure and response prevention with heavy smokers: a laboratory-based randomised placebo-controlled trial examining the effects of D-cycloserine on cue reactivity and attentional bias.
    Kamboj SK; Joye A; Das RK; Gibson AJ; Morgan CJ; Curran HV
    Psychopharmacology (Berl); 2012 May; 221(2):273-84. PubMed ID: 22101394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.